Press Releases

May 03, 2017

23andMe and German Pain Specialist Grünenthal Explore the Genetics of Pain to Help Identify New Treatments for Patients

May 3, 2017 – Mountain View, Calif., and Aachen, Germany – Today 23andMe, Inc. and Grünenthal announced a joint study to better understand how genes influence pain. Together, they seek…
April 06, 2017

23andMe, Inc. Granted First FDA Authorization to Market Direct-to-Consumer Genetic Health Risk Reports

Genetic risk reports for Alzheimer’s disease, Parkinson’s disease and Hereditary Thrombophilia included in the FDA authorization, among othersMountain View, California – April 6, 2017 – 23andMe, Inc., the leading personal…
February 22, 2017

Celmatix and 23andMe Announce Launch of Fertility Research Community

Companies to recruit 4,500 women for ambitious Celmatix longitudinal study to identify new markers related to reproductive healthNEW YORK- February 22, 2017, Celmatix, a next-generation women’s health company, and 23andMe,…